<VariationArchive VariationID="573823" VariationName="NM_054012.4(ASS1):c.319del (p.Gln107fs)" VariationType="Deletion" Accession="VCV000573823" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="565573" VariationID="573823">
      <GeneList>
        <Gene Symbol="ASS1" FullName="argininosuccinate synthase 1" GeneID="445" HGNC_ID="HGNC:758" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="130444707" stop="130501274" display_start="130444707" display_stop="130501274" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="133320093" stop="133376660" display_start="133320093" display_stop="133376660" Strand="+" />
          </Location>
          <OMIM>603470</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_054012.4(ASS1):c.319del (p.Gln107fs)</Name>
      <CanonicalSPDI>NC_000009.12:130458542:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="130458543" stop="130458543" display_start="130458543" display_stop="130458543" variantLength="1" positionVCF="130458542" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="133333930" stop="133333930" display_start="133333930" display_stop="133333930" variantLength="1" positionVCF="133333929" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Q107fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.133333932del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.133333932del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.130458545del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.130458545del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011542.1" sequenceAccession="NG_011542" sequenceVersion="1" change="g.18839del">
            <Expression>NG_011542.1:g.18839del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000050.4" sequenceAccession="NM_000050" sequenceVersion="4" change="c.319del">
            <Expression>NM_000050.4:c.319del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000041.2" sequenceAccession="NP_000041" sequenceVersion="2" change="p.Gln107fs">
            <Expression>NP_000041.2:p.Gln107fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_054012.4" sequenceAccession="NM_054012" sequenceVersion="4" change="c.319del" MANESelect="true">
            <Expression>NM_054012.4:c.319del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_446464.1" sequenceAccession="NP_446464" sequenceVersion="1" change="p.Gln107fs">
            <Expression>NP_446464.1:p.Gln107fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000050.4" sequenceAccession="NM_000050" sequenceVersion="4" change="c.319delC">
            <Expression>NM_000050.4:c.319delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1564903969" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_054012.4(ASS1):c.319del (p.Gln107fs) AND Citrullinemia type I" Accession="RCV000695591" Version="3">
        <ClassifiedConditionList TraitSetID="1757">
          <ClassifiedCondition DB="MedGen" ID="C4721769">Citrullinemia type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-16" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_054012.4(ASS1):c.319del (p.Gln107fs) AND Citrullinemia" Accession="RCV002233293" Version="3">
        <ClassifiedConditionList TraitSetID="64881">
          <ClassifiedCondition DB="MedGen" ID="C0175683">Citrullinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-02-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-16" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18473344</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19006241</ID>
        </Citation>
        <DescriptionHistory Dated="2020-06-22">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="64881" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="54673" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Citrullinemia</ElementValue>
                <XRef ID="MONDO:0015991" DB="MONDO" />
                <XRef ID="398680004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Citrullinuria</ElementValue>
                <XRef ID="HP:0032397" DB="Human Phenotype Ontology" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CTNL1</ElementValue>
                <XRef ID="GTR000558544" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16522" />
                <XRef ID="16522" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="187" DB="Orphanet" />
              <XRef ID="C0175683" DB="MedGen" />
              <XRef ID="MONDO:0015991" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS215700" DB="OMIM" />
              <XRef Type="primary" ID="HP:0032397" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1757" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1459" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Classic citrullinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Citrullinemia 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">argininosuccinate synthetase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Citrullinemia type I</ElementValue>
                <XRef ID="Citrullinemia+Type+I/1651" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008988" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CTNL1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CTLN1</ElementValue>
                <XRef Type="MIM" ID="215700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6114" />
                <XRef ID="6114" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Citrullinemia type I (CTLN1) presents as a spectrum that includes a neonatal acute form (the "classic" form), a milder late-onset form (the "non-classic" form), a form in which women have onset of symptoms at pregnancy or post partum, and a form without symptoms or hyperammonemia. Distinction between the forms is based primarily on clinical findings, although emerging evidence suggests that measurement of residual argininosuccinate synthase enzyme activity may help to predict those who are likely to have a severe phenotype and those who are likely to have an attenuated phenotype. Infants with the acute neonatal form appear normal at birth. Shortly thereafter, they develop hyperammonemia and become progressively lethargic, feed poorly, often vomit, and may develop signs of increased intracranial pressure (ICP). Without prompt intervention, hyperammonemia and the accumulation of other toxic metabolites (e.g., glutamine) result in increased ICP, increased neuromuscular tone, spasticity, ankle clonus, seizures, loss of consciousness, and death. Children with the severe form who are treated promptly may survive for an indeterminate period of time, but usually with significant neurologic deficits. Even with chronic protein restriction and scavenger therapy, long-term complications such as liver failure and other (rarely reported) organ system manifestations are possible. The late-onset form may be milder than that seen in the acute neonatal form, but commences later in life for reasons that are not completely understood. The episodes of hyperammonemia are similar to those seen in the acute neonatal form, but the initial neurologic findings may be more subtle because of the older age of the affected individuals. Women with onset of severe symptoms including acute hepatic decompensation during pregnancy or in the postpartum period have been reported. Furthermore, previously asymptomatic and non-pregnant individuals have been described who remained asymptomatic up to at least age ten years, with the possibility that they could remain asymptomatic lifelong.</Attribute>
                <XRef ID="NBK1458" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301631</ID>
                <ID Source="BookShelf">NBK1458</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301396</ID>
                <ID Source="BookShelf">NBK1217</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, ACT Sheet, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrullinemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, [Elevated Citrulline], Amino Acidemia/Urea Cycle Disorder, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrulline-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Elevated Citrulline: Amino Acidemia Algorithm, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Citrullinemia-I-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Citrullinemia I, Urea Cycle Disorder, 2012</CitationText>
              </Citation>
              <XRef ID="247525" DB="Orphanet" />
              <XRef ID="C4721769" DB="MedGen" />
              <XRef ID="MONDO:0008988" DB="MONDO" />
              <XRef Type="MIM" ID="215700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2669575" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000050.4:c.319del|MedGen:C0175683" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001361256" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: ASS1 c.319delC (p.Gln107SerfsX33) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (c.892delG, p.Glu298fsX18; c.1030C&gt;T, p.Arg344X). The variant was absent in 249828 control chromosomes (gnomAD). To our knowledge, no occurrence of c.319delC in individuals affected with Citrullinemia Type I and no experimental evidence demonstrating its impact on protein function have been reported. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000050.4:c.319del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Citrullinuria</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0175683" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1595888" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="3741667|MedGen:C0175683" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000824101" DateUpdated="2024-02-14" DateCreated="2018-10-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18473344</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19006241</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ASS1 are known to be pathogenic (PMID: 18473344, 19006241). This variant has not been reported in the literature in individuals with ASS1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln107Serfs*33) in the ASS1 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.133333930del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0175683" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2669575" TraitType="Disease" MappingType="Name" MappingValue="Citrullinuria" MappingRef="Preferred">
        <MedGen CUI="C0175683" Name="Citrullinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1595888" TraitType="Disease" MappingType="XRef" MappingValue="C0175683" MappingRef="MedGen">
        <MedGen CUI="C0175683" Name="Citrullinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

